Sigma Planning Corp’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,119
Closed -$957K 1250
2024
Q3
$957K Buy
+15,119
New +$957K 0.03% 517